Our microbe-inspired protein scaffolding platform is enabling the rapid engineering and validation of next-generation biopharmaceuticals with superior pharmacological properties, without the need for injection.

​​​Applied Molecular Transport is developing a transformative pipeline of oral and targeted biological therapeutics that promise to redefine the future of biopharmaceuticals.


The company's core therapeutic areas of focus are Autoimmune Diseases & Inflammation, and Metabolic Diseases & Diabetes.

    January 23, 2017,

    Robert Baughman, PharmD, PhD joins

​    Applied Molecular Transport as

    Chief​ Development Officer.

   

Copyright © APPLIED MOLECULAR TRANSPORT, LLC 2016. All rights reserved.

​​​Our microbe-inspired protein scaffolding, cellular translocation and targeting platform is enabling next-generation biopharmaceuticals with superior pharmacological properties and enhanced safety profiles.

​​Applied Molecular Transport is developing a transformative pipeline of oral biological therapeutics that promise to redefine the future of biopharmaceuticals.


The company's core focus is in the areas of immune-mediated inflammation and metabolic diseases.